Enterprise Pharmacy Forward

Latest

Pharmacy Stars platform drives systemwide standardization in compounding competencies

Authors: Heidi Yanoski and Adam Castro Over the past year, the transition of Geisinger’s aseptic technique competencies to the Pharmacy Stars® online platform was successfully completed, with the official launch occurring on March 1, 2025. This initiative involved extensive cross-departmental planning and customization to meet systemwide requirements. Instructional

Restoring cleanroom integrity: HVAC renovations at 2 primary compounding locations

Author: Adam Castro In 2024, Geisinger completed critical heating, ventilation and air conditioning (HVAC) renovations at 2 of its primary sterile compounding locations — Geisinger Wyoming Valley (GWV) operating rooms and Geisinger Medical Center (GMC) Hematology/Oncology Biologics Pharmacy suite. These upgrades addressed longstanding environmental control challenges that directly impacted sterile

Expanding Care Beyond Walls: Launching Geisinger’s Hospital at Home Program

Authors: Michelle Budzyn, PharmD, BCPS and Kelly Bolesta, PharmD, BCPS Geisinger’s Hospital at Home program is an innovative initiative that offers patients hospital-level care from the comfort of their own homes. The program allows patients to remain close to family, friends and pets; avoid unnecessary exposure to infection;

Standardizing Broselow carts: Elevating pediatric emergency care across Geisinger

Author: Emma Wysocki Since their development in the 1980s, Broselow carts have revolutionized pediatric emergency medicine by streamlining access to lifesaving equipment and supplies. Broselow carts are organized into color-coded drawers that correspond to specific length and weight ranges and have consistently demonstrated several advantages over standard code carts

Gene therapy administration: A collaborative model for complex care

Author: Sarah Hale Geisinger continues to expand its capabilities in delivering advanced therapies. Among the most notable are gene therapies for pediatric patients, including onasemnogene abeparvovec-xioi (Zolgensma) for spinal muscular atrophy (SMA) and delandistrogene moxeparvovec-rokl (Elevidys) for Duchenne muscular dystrophy (DMD). These treatments represent some of the most

Medication reconciliation transformation: Enhancing safety across the care continuum

Author: Brian Simpkins Geisinger has launched a multi-phase initiative to improve medication reconciliation processes across the system, with a focus on strengthening patient safety and care continuity from admission through discharge. The effort addresses longstanding challenges related to medication accuracy, workflow consistency and system integration. The initial phase targets

Expanding behavioral health pharmacy services through the Geisinger–Acadia Partnership

Author: Brian Simpkins In 2023, Geisinger and Acadia Healthcare launched a joint venture to expand behavioral health services across the Geisinger service region. The partnership began with the opening of Geisinger Behavioral Health Northeast in Moosic, Pa., followed by the launch of a second facility in Danville in August 2025.